S&P assigns ‘A+’ rating to El Camino Hospital’s bonds

S&P Global Ratings assigned an “A+” rating to Mountain View, Calif.-based El Camino Hospital’s series 2016A bonds.

Advertisement

S&P also affirmed the “A+” rating on ECH’s series 2015A bonds.

“The ratings reflect our assessment of ECH’s exceptional operating margins, abundant unrestricted reserves for the rating, considerable tax support and favorable economic fundamentals in the operating environment,” said S&P analyst Brian Williamson.

The outlook is stable, reflecting S&P’s view of ECH’s strong financial profile and favorable service area characteristics.

More articles on healthcare finance:
5 most-read finance stories: Week of Oct. 17-21
Cedars-Sinai operating margin dips slightly to 9.3%
Moody’s assigns ‘A1’ rating to El Camino Hospital’s bonds

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.